Bacterial topoisomerase inhibitor

This page covers all Bacterial topoisomerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA gyrase and topoisomerase IV.

Targets

DNA gyrase and topoisomerase IV

Phase 3 pipeline (1)

• Placebo matching gepotidacin · GlaxoSmithKline · Infectious Disease
  Gepotidacin is a novel bacterial topoisomerase inhibitor that prevents bacterial DNA replication and transcription by targeting DNA gyrase and topoisomerase IV.

Patent intelligence

• bacterial topoisomerase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates